从良性到恶性:垂体神经内分泌瘤 (PitNETs) 的到来
1Address of Correspondent: Munich Re, 1000 Rue de la Gauchetière Ouest, 20e étage, Montréal Québec, H3B 4W5; 514-392-5069; tmeagher@munichre.ca.
Journal of insurance medicine (New York, N.Y.)
|February 15, 2024
概括
垂体腺瘤现在被归类为神经内分泌瘤,一种癌症. 这种重新分类需要改变以前将其作为良性脑瘤所涵盖的危急疾病保险政策.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 医疗政策 医疗政策
背景情况:
- 以前被认为是良性脑瘤的垂体腺瘤经历了显著的分类学转变.
- 最近的重新分类将下垂体腺瘤指定为神经内分泌瘤,使其与癌症分类保持一致.
研究的目的:
- 描述下垂体腺瘤重新分类背后的演变和理由.
- 突出这一变化对重症病保险政策的影响.
- 在政策语言中解决"良性"和"瘤"等术语所带来的语义挑战.
主要方法:
- 审查科学文献和对垂体腺瘤的诊断标准.
- 分析当前关于脑瘤的重症病政策规定.
- 检查更新的医疗分类学对保险覆盖的影响.
主要成果:
- 垂体腺瘤现在被正式认定为神经内分泌瘤,包括癌症在内的类别.
- 现有的重症病政策需要修改,以反映这一新分类.
- 这种重新分类引发了关于保险中继续适当使用"良性"和"瘤"术语的问题.
结论:
- 将垂体腺瘤重新归类为癌症需要对重症病保险框架进行审查和更新.
- 保险公司必须调整政策语言,以准确地反映当前的医疗理解,并确保适当的覆盖.
- 这种分类学变化强调了医学分类的动态性质及其对医疗保健政策的直接影响.
更多相关视频
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
